PANACEA BIOTEC
Back to Income Statement
|
PANACEA BIOTEC Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-8.37 Cr | ₹-1.17 Cr | ₹-33 Cr | ₹1,078 Cr | ₹-148 Cr |
What is the latest Consolidated Net Profit of PANACEA BIOTEC ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-8.37 Cr |
| Mar2024 | ₹-1.17 Cr |
| Mar2023 | ₹-33 Cr |
| Mar2022 | ₹1,078 Cr |
| Mar2021 | ₹-148 Cr |
How is Consolidated Net Profit of PANACEA BIOTEC Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-8.37 Cr | Negative | |
| Mar2024 | ₹-1.17 Cr | Negative | |
| Mar2023 | ₹-33 Cr | Negative | |
| Mar2022 | ₹1,078 Cr | Positive | |
| Mar2021 | ₹-148 Cr | - | |
Compare Consolidated Net Profit of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,122.2 Cr | -5.6% | -11.5% | -14.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,363.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,193.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,519.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,940.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | -5.6% |
-11.5% |
-14.2% |
| SENSEX | -0.9% |
-0.1% |
7% |
You may also like the below Video Courses